Why Reversing Biological Age Misses the Point

A physician’s guide to what works, what’s promising, and what’s premature.

In recent months, I’ve received countless questions from patients and colleagues about “reversing biological age.” The idea is compelling and the science is evolving, but the conversation is often more hype than medicine.

This essay explores what the data actually say, how to separate proven longevity interventions from speculation, and why “younger” biomarkers don’t always mean longer life.

We are living in a remarkable moment in medicine and wellness. Nearly every week brings a new headline claiming a discovery that “reverses biological age.” These reports, whether about medications, supplements, dietary plans, or more exotic therapies like hyperbaric oxygen treatment, often make bold promises without sufficient context.

As a physician focused on preventive and longevity medicine, I find the enthusiasm encouraging but the interpretation often misleading. People are understandably drawn to headlines that promise the fountain of youth and to high-profile figures like Bryan Johnson, who has spent millions in pursuit of “cheating death.” While their dedication reflects a genuine fascination with human potential, it can also oversimplify what is, in truth, a complex and evolving field.

In my practice, I think about longevity interventions in three tiers:

Tier 1: Proven foundations

Measures with strong evidence for extending both lifespan and healthspan: regular physical activity, high-quality nutrition such as Mediterranean or DASH-style diets, restorative sleep, stress management, and control of metabolic risk factors. They are safe, universally beneficial, and form the cornerstone of any longevity plan.

Tier 2: Promising but not yet proven

Approaches that show early biological plausibility and appear relatively low risk. Examples include caloric restriction or intermittent fasting, metformin and other caloric-restriction mimetics, NAD⁺ precursors such as NMN or nicotinamide riboside, omega-3s, vitamin D, and circadian optimization. They can be valuable additions when monitored thoughtfully, though evidence for long-term benefit is still emerging.

Tier 3: Speculative or high-risk

Interventions often marketed as “age-reversing” despite limited or inconsistent data. These include hyperbaric oxygen therapy, stem-cell or exosome infusions, growth-hormone-based peptide regimens, cryotherapy, ozone or IV “longevity drips,” and young plasma transfusions. They are expensive, largely unregulated, and in some cases carry measurable risk.

This framework helps patients focus on what truly matters: pursuing interventions that enhance quality of life and long-term function, while approaching experimental or high-cost options with healthy skepticism.

Before we can claim to reverse aging, we need to define what biological aging actually means and how it can be measured.

What Are the Established Indicators of Biological Aging?

Biological age aims to capture how well the body is functioning relative to time, rather than simply counting years lived. The best-established indicators are telomere length and DNA methylation-based epigenetic clocks, which measure age-related changes at specific CpG sites in the genome. These biomarkers reflect different dimensions of aging and only modestly correlate with each other (1-8).

Telomere length shortens with each cell division and is linked to cellular senescence and chronological age. Although it remains a recognized hallmark of aging, its predictive value for health outcomes is limited by measurement variability and modest correlation with disease risk (5). Telomere length is influenced by genetics, lifestyle, and underlying illness.

Epigenetic clocks, in contrast, estimate biological age using DNA methylation patterns. Models such as Horvath, Hannum, PhenoAge, and GrimAge are strongly correlated with chronological age and predict mortality, frailty, and functional decline (1-4, 6-8). The concept of epigenetic age acceleration—when methylation age exceeds chronological age—has been associated with increased risk of cardiovascular disease, neurodegeneration, and overall mortality (3, 4, 7).

Epigenetic clocks generally outperform telomere length in predicting age-related outcomes and are currently the most accurate laboratory measures of biological age (1, 2, 5, 6). Other emerging markers, such as systemic inflammation (for example, C-reactive protein), proteomic and metabolomic profiles, and physiologic indices like grip strength or vascular stiffness, add complementary information but are less specific to aging itself (7, 8).

In short, telomere length and epigenetic clocks are useful research tools but remain correlates, not proven causes, of aging.

Do Interventions Actually Reverse These Markers?

Evidence suggests that some interventions can shift biological-age markers in a younger direction. Lifestyle measures remain the most effective and reliable, while more experimental approaches show promise but need longer-term validation (9-17).

Tier 1: Lifestyle foundations

High-quality nutrition, physical activity, adequate sleep, and stress reduction are consistently linked to slower biological aging and reduced risk of chronic disease. Randomized trials show that improved diet quality and increased physical activity slow the progression of epigenetic clocks and reduce methylation errors (9-13). These behaviors improve longevity regardless of what the biomarkers show.

Tier 2: Emerging and relatively low-risk interventions

Caloric restriction and intermittent fasting have been shown to slow the pace of aging by certain measures (14), and while human data are still evolving, these approaches are generally safe and often beneficial for metabolic health. Supplements such as omega-3s, vitamin D, and polyphenols fall into the same low-risk, potentially helpful category (10, 13).

By contrast, pharmacologic agents such as metformin and rapamycin analogues warrant more caution (15, 16). Although they show mechanistic promise and intriguing results in animal studies, translation to humans has been inconsistent. The variability in findings and the absence of definitive long-term data should give pause before committing to daily, lifelong medication use without clear evidence of benefit. It is also worth questioning the practicality of such an approach when there are no appreciable improvements in how one feels on a day-to-day basis.

Tier 3: Speculative or high-risk interventions

Claims of “age reversal” through hyperbaric oxygen therapy, stem-cell infusions, peptide cocktails, or cryotherapy lack credible long-term evidence (16). Other examples include ozone therapy, IV “longevity drips,” and parabiosis transfusions. These interventions are expensive, time-intensive, and may expose patients to unnecessary risk without clear benefit.

Most important, even when biomarkers shift favorably, that does not prove the aging process itself has been reversed.

Reliability and Validity of Biological-Age Tests

The tests themselves are not perfectly reliable. Independent analyses show that retesting the same sample can yield differences of three to nine years in predicted biological age. Some early-generation epigenetic clocks give inconsistent results when compared across laboratories, raising the possibility that reported “age reversals” may reflect measurement noise rather than true biological change.

Variability stems from differences in algorithms, sample type (blood versus saliva), batch effects, and company-specific calibration. When a test claims that biological age has dropped by two years, that change may fall within the test’s margin of error.

My professional recommendation is not to invest in these tests at this stage. They are interesting research tools but provide little practical value for most patients. The information rarely changes management, and the cost is better spent on interventions already known to improve healthspan.

If you choose to explore one out of curiosity, interpret the results cautiously. Use the same laboratory, the same sample type, and allow at least a year between tests. These tools are best viewed as directional indicators, not definitive verdicts on one’s biological state.

Does Reversing a Biomarker Extend Life or Improve Healthspan?

Even if a marker such as telomere length or methylation age improves, that does not necessarily translate into longer life or better health. For example, hyperbaric oxygen treatment has been shown to lengthen telomeres temporarily, but there is no evidence that it increases lifespan or functional capacity (16, 17). Excessive activation of telomerase, in fact, has been associated with elevated cancer risk in some models.

Until we see durable, clinically meaningful improvements—better strength, cognition, and disease resilience—we should remain cautious about equating biomarker shifts with genuine reversal of aging.

What Should We Really Be Measuring

The purpose of longevity medicine is not to chase biomarkers but to enhance function, resilience, and quality of life.

Tier 1 measures—nutrition, exercise, sleep, stress management, and metabolic fitness—consistently improve lifespan and healthspan.

Tier 2 strategies may complement the foundation when used thoughtfully and monitored appropriately.

Tier 3 claims often distract from the fundamentals and may introduce unnecessary expense or risk.

If an intervention improves energy, mobility, cognition, and overall wellbeing safely and sustainably, it is meaningful, regardless of what a test report says.

The Takeaway

The science of aging is advancing quickly, and the excitement is justified. Yet the narrative of “reversing biological age” often moves faster than the data. By organizing interventions into what is proven, promising, and premature, we can guide patients toward the strategies that truly matter: living longer, better, and with purpose.

True longevity is not about measuring younger; it is about thriving longer.

Erik Schraga, MD, is a concierge physician at CrescendoMD in Portola Valley, California. His practice focuses on preventive and longevity medicine for adults and families seeking personalized, high-touch care.